News
Stories about the companies we track, gathered daily from UK and European tech press and Google News. Headlines link to the original publisher.
13 storiesCellCentric ✕
Clear all- FundingBusiness Weekly, 16 Sept 2026CellCentric wins Business of the Year at 36th Business Weekly Awards ahead of tipped US IPO
- FundingBioXconomy, 13 May 2026CellCentric potentially make a late-stage crawl towards IPO
- FundingFierce Biotech, 6 May 2026CellCentric raises $220M series D to advance myeloma drug through registration, eyes potential IPO
- Otherpharmaphorum, 6 May 2026CellCentric pockets $220m for blood cancer programme
- OtherBusiness Wire, 31 Mar 2026CellCentric Initiates DOMMINO-1, a Pivotal Phase 2 Clinical Trial of Inobrodib in Combination with Pomalidomide and Dexamethasone (InoPd) in Relapsed or Refractory Multiple Myeloma
- OtherBusiness Weekly, 2 Sept 2025CellCentric advances blood cancer trial
- OtherHealthInvestor UK, 29 May 2025CellCentric: Celia Economides
- Leadershipbusinesscloud.co.uk, 27 May 2025BioTech CellCentric announces new chief financial officer
- OtherBusiness Weekly, 27 May 2025CellCentric continues uptick with key executive hire
- FundingCambridge Independent, 26 May 2025CellCentric’s Series C $120m is a huge boost for myeloma drug inobrodib
- OtherEndpoints News, 19 May 2025Exclusive: CellCentric collects $120M to treat multiple myeloma with a capsule
- FundingFierce Biotech, 19 May 2025Pfizer-backed CellCentric secures $120M for further myeloma trials
- ExpansionFierce Biotech, 2 Apr 2025British biotech CellCentric expands to Boston with plans to grow into late-stage clinical development
